Comparative Pharmacokinetics of Tixagevimab/Cilgavimab ( AZD7442 ) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV ‐2 Infection

Author:

Bender Ignacio Rachel A.12ORCID,Wohl David A.3ORCID,Arends Rosalin4,Pilla Reddy Venkatesh4ORCID,Mu Ying5,Javan Arzhang Cyrus6,Hughes Michael D.7,Eron Joseph J.3ORCID,Currier Judith S.8ORCID,Smith Davey9ORCID,Chew Kara W.8ORCID,Gibbs Michael4,Fletcher Courtney V.5ORCID

Affiliation:

1. Division of Allergy and Infectious Diseases University of Washington Seattle Washington USA

2. Vaccine and Infectious Diseases Division Fred Hutchinson Cancer Center Seattle Washington USA

3. Institute of Global Health and Infectious Diseases University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

4. Clinical Pharmacology and Quantitative Pharmacology, Vaccines & Immunotherapies, Neuroscience and Clinical Immunogenicity AstraZeneca Cambridge UK

5. UNMC Center for Drug Discovery University of Nebraska Medical Center Omaha Nebraska USA

6. Division of AIDS National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda Maryland USA

7. Harvard T.H. Chan School of Public Health Boston Massachusetts USA

8. Division of Infectious Diseases David Geffen School of Medicine at University of California Los Angeles Los Angeles California USA

9. Division of Infectious Diseases and Global Public Health University of California – San Diego San Diego California USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3